Pernix Therapeutics Holdings, Inc.
PTX
PTX was delisted on the 4th of March, 2019.
48 hedge funds and large institutions have $8.18M invested in Pernix Therapeutics Holdings, Inc. in 2016 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 9 increasing their positions, 14 reducing their positions, and 16 closing their positions.
48% more capital invested
Capital invested by funds: $5.52M → $8.18M (+$2.65M)
14% less funds holding
Funds holding: 56 → 48 (-8)
36% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 14
50% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 16
94% less call options, than puts
Call options by funds: $3K | Put options by funds: $49K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$1.62M |
| 2 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$555K |
| 3 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$153K |
| 4 |
JG
Jefferies Group
New York
|
+$123K |
| 5 |
SC
Searle & Co
Greenwich,
Connecticut
|
+$106K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AQR Capital Management
Greenwich,
Connecticut
|
-$645K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$554K |
| 3 |
Tudor Investment Corp
Stamford,
Connecticut
|
-$97K |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$89K |
| 5 |
MC
Menta Capital
San Francisco,
California
|
-$87K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CS
51
Credit Suisse
Zurich,
Switzerland
| – | -$72K | -16,069 | Closed |
|
52
Jane Street
New York
| – | -$33K | -7,398 | Closed |
|
53
D.E. Shaw & Co
New York
| – | -$15K | -3,400 | Closed |
|
54
New York State Common Retirement Fund
Albany,
New York
| – | -$9K | -1,980 | Closed |
|
|
TRCT
55
Tower Research Capital (TRC)
New York
| – | -$7K | -1,469 | Closed |
|
56
Balyasny Asset Management
Chicago,
Illinois
| – | -$5K | -1,170 | Closed |
|
|
JMPWA
57
JP Morgan Private Wealth Advisors
San Francisco,
California
| – | -$5K | -1,148 | Closed |
|
58
Barclays
London,
United Kingdom
| – | -$3K | -486 | -89% |
|
PTX Hedge Fund Activity: Q3 2016 in Review
48 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Pernix Therapeutics Holdings, Inc. (PTX) for Q3 2016, worth a combined $8.18M — up 48% from $5.52M a quarter earlier.
Sellers outnumbered buyers: 16 funds closed out of PTX and 8 opened new positions — a net loss of 8 holders — while 14 trimmed existing stakes and 9 added.
The largest buyer was Renaissance Technologies, adding an estimated $1.62M. The largest seller was AQR Capital Management, exiting entirely with an estimated $645K sold.
- 48 institutional investors held Pernix Therapeutics Holdings, Inc. (PTX) as of Q3 2016, down from 56 in Q2 2016.
- Funds reported $8.18M of Pernix Therapeutics Holdings, Inc. stock for Q3 2016, up 48% quarter-over-quarter.
- 8 funds opened new Pernix Therapeutics Holdings, Inc. positions in Q3 2016 and 16 closed out, a net change of -8 holders.
- The largest Pernix Therapeutics Holdings, Inc. buyer in Q3 2016 was Renaissance Technologies, an estimated $1.62M added.
- The largest Pernix Therapeutics Holdings, Inc. seller in Q3 2016 was AQR Capital Management, an estimated $645K sold.
Based on aggregated 13F filings for Q3 2016.